CTRI/2025/01/079246尚未招募不适用
Model for end-stage liver disease-3.0 and model for end-stage liver disease-sodium in predicting mortality in cirrhosis- A comparative study
未提供1 个研究点 分布在 1 个国家目标入组 142 人开始时间: 2025年2月3日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 142
- 试验地点
- 1
- 主要终点
- To compare MELD-Na and MELD 3.0 in predicting the 30 days and 90 days mortality, liver transplantation and death in patients with cirrhosis
研究概览
简要总结
After obtaining written informed consent and checking for exclusion criteria, patients with
cirrhosis will be enrolled in the study.
Information regarding relevant History, physical examination, demographic and laboratory
parameters will be entered in a preformatted data sheet.
S. albumin, S. sodium, S. creatinine, INR, Sex of the study participant, S. bilirubin will be used
to calculate MELD, MELD-Na, MELD 3.0 scores.
Patients will be followed for 3 months mortality or liver transplantation.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 80.00 Year(s)（—）
- 性别
- All
入选标准
- •Age of 18 and above, irrespective of gender.
- •Patients diagnosed with liver cirrhosis and clinically significant portal hypertension based on clinical, radiological, and biochemical parameters.
排除标准
- •ACLF Ischemic hepatitis Hepatocellular carcinoma Any extrahepatic malignancy with a life expectancy of less than 3 months Any severe extrahepatic disease that has an impact on survival of less than 3 months.
结局指标
主要结局
To compare MELD-Na and MELD 3.0 in predicting the 30 days and 90 days mortality, liver transplantation and death in patients with cirrhosis
时间窗: 0, 28 and 90 days
次要结局
- Gender specific mortality and etiology specific mortality prediction using MELD-Na and MELD-3.0 scores.(0, 28 and 90 days)
研究者
Dr Ganesh Bhat
Kasturba Medical College
研究点 (1)
Loading locations...
相似试验
招募中
不适用
To Study the Clinical Course and Outcomes of Hospitalised Patients. of Liver Cirrhosis with organ failure.CTRI/2025/11/097053Institute of Liver and Biliary Sciences100
招募中
不适用
Using Autologous Bone Marrow Cells With Wharton Gel Exosomes to Stimulate Hepatic Cell Repair in Liver CirrhosisLiver CirrhosisNCT07374185Global Stem Cell Center, Baghdad10
招募中
2 期
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)Liver CirrhosisNCT07325526Boehringer Ingelheim30
招募中
不适用
The Liver Cirrhosis Cognitive Decline Scale (LiCCoS)Liver CirrhosisHepatic EncephalopathyNCT07418008University of Malaya230
尚未招募
不适用
Preliminary Evaluation of Clinical Application of SPECT Imaging Targeting GPC3NCT07353333Union Hospital, Tongji Medical College, Huazhong University of Science and Technology6